Recursion Pharmaceuticals Inc Cl A (RXRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 06-2023 | 03-2023 | 12-2022 | 09-2022 | 06-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -142,053 | -65,327 | -239,476 | -181,984 | -121,539 |
| Depreciation Amortization | 9,271 | 3,728 | 11,756 | 8,542 | 5,553 |
| Accounts receivable | -1,131 | -317 | N/A | -5,574 | -9,351 |
| Accounts payable and accrued liabilities | -2,856 | -339 | 1,767 | 1,072 | 358 |
| Other Working Capital | -34,525 | -24,404 | 104,921 | 105,522 | 113,287 |
| Other Operating Activity | 30,511 | 13,343 | 37,508 | 33,646 | 27,457 |
| Operating Cash Flow | $-140,783 | $-73,316 | $-83,524 | $-38,776 | $15,765 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | 230,608 | 230,608 | 169,061 |
| PPE Investments | -9,143 | -5,175 | -37,059 | -29,080 | -20,817 |
| Net Acquisitions | 1,915 | N/A | N/A | N/A | N/A |
| Purchase Sale Intangibles | -165 | -165 | -300 | -300 | 0 |
| Other Investing Activity | -165 | -165 | -300 | -300 | 0 |
| Investing Cash Flow | $-7,393 | $-5,340 | $193,249 | $201,228 | $148,244 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | -48 | -24 | -90 | -67 | -44 |
| Common Stock Issued | N/A | 0 | 143,711 | N/A | N/A |
| Other Financing Activity | 5,757 | 1,946 | 10,724 | 7,156 | 4,796 |
| Financing Cash Flow | $5,709 | $1,922 | $154,345 | $7,089 | $4,752 |
| Exchange Rate Effect | 179 | -2 | -307 | N/A | 0 |
| Beginning Cash Position | 559,112 | 559,112 | 295,349 | 295,349 | 295,349 |
| End Cash Position | 416,824 | 482,378 | 559,112 | 464,890 | 464,110 |
| Net Cash Flow | $-142,288 | $-76,734 | $263,763 | $169,541 | $168,761 |
| Free Cash Flow | |||||
| Operating Cash Flow | -140,783 | -73,316 | -83,524 | -38,776 | 15,765 |
| Capital Expenditure | -9,143 | -5,175 | -37,059 | -29,080 | -20,817 |
| Free Cash Flow | -149,926 | -78,491 | -120,583 | -67,856 | -5,052 |